oral anticoagulant
Showing 1 - 25 of >10,000
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments
Completed
- Hemophilia A
- +2 more
- Vitamin K Antagonist - Drug
-
Brest, France
- +5 more
Apr 6, 2023
Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)
Recruiting
- Ischemic Stroke
- Anticoagulant Adverse Reaction
- Dabigatran, rivaroxaban, apixaban, edoxaban
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2023
Anticoagulants Trial in Hamilton (Anticoagulation Coordinated Care)
Completed
- Anticoagulants
- Anticoagulation Coordinated Care
-
Hamilton, Ontario, CanadaSt Joseph's Healthcare Hamilton
Oct 25, 2022
Atrial Fibrillation and Heart Failure Who Are ReceivingDirect
Completed
- Heart Failure
- Rivaroxaban (Xarelto, BAY59-7939)
-
Multiple Locations, SpainMany Locations
Dec 29, 2022
Oral Anticoagulant, Adherence Trial in Amiens (questionary)
Recruiting
- Oral Anticoagulant
- Adherence
- questionary
-
Amiens, FranceCHU Amiens
Jul 27, 2022
Acute DVT of Lower Extremity Trial (New oral anticoagulant (rivaroxaban) and Marevan (warfarin))
Not yet recruiting
- Acute DVT of Lower Extremity
- New oral anticoagulant (rivaroxaban) and Marevan (warfarin)
- (no location specified)
Nov 21, 2023
Atrial Fibrillation, Obesity, Prognosis Trial in Suwon (Oral anticoagulant)
Active, not recruiting
- Atrial Fibrillation
- +3 more
- Oral anticoagulant
-
Suwon, Gyeong-gido, Korea, Republic ofAjou University School of Medicine
Dec 11, 2022
Oral Anticoagulant Therapy Trial in Buenos Aires (Dental implant surgery)
Completed
- Oral Anticoagulant Therapy
- Dental implant surgery
-
Buenos Aires, ArgentinaMasters in Dental Implantology (MIO) program at the University o
Oct 9, 2022
Non-vitamin K Antagonist Oral Anticoagulant Concentration and
Recruiting
- Atrial Fibrillation
- Data collection
-
Taipei, Please Select, Taiwan
- +1 more
Apr 17, 2022
Atrial Fibrillation, Pulmonary Embolism Trial in Stockholm (Zenicor intermittent ECG device, 5 day ECG patch)
Terminated
- Atrial Fibrillation
- Pulmonary Embolism
- Zenicor intermittent ECG device
- 5 day ECG patch
-
Stockholm, SwedenDanderyd Hospital
Jul 26, 2022
Non-paroxysmal Atrial Fibrillation Trial in Beijing (Thoracoscopic LAA clipping, Novel oral anticoagulant)
Not yet recruiting
- Non-paroxysmal Atrial Fibrillation
- Thoracoscopic LAA clipping
- Novel oral anticoagulant
-
Beijing, Beijing, ChinaChina National Center for Cardiovascular Diseases
Aug 31, 2023
Post Biopsy Bleeding Trial in Shatin (Endoclip)
Recruiting
- Post Biopsy Bleeding
- Endoclip
-
Shatin, New Territories, Hong KongPrince of Wales Hospital
Mar 7, 2022
Baseline Concentration of Direct Oral Anticoagulant and
Recruiting
- Atrial Fibrillation
- Anticoagulant-induced Bleeding
-
Cremona, ItalySophie Testa
Jul 19, 2022
Aortic Valve Disease Trial in Paris (Apixaban 5 MG Oral Tablet, warfarin with an objective of INR target of 2.5 (range:
Not yet recruiting
- Aortic Valve Disease
- Apixaban 5 MG Oral Tablet
- warfarin with an objective of INR target of 2.5 (range: 2.0-3.0)
-
Paris, FranceService de Cardiologie Hôpital Lariboisière
Jan 24, 2023
Subdural Hematoma, Atrial Fibrillation Trial in Toronto (Direct Acting Oral Anticoagulant starting at Day 30, Direct Acting Oral
Not yet recruiting
- Subdural Hematoma
- Atrial Fibrillation
- Direct Acting Oral Anticoagulant starting at Day 30
- Direct Acting Oral Anticoagulant starting at Day 90
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jul 26, 2022
Medicines That Help in Thinning Blood in People With Atrial
Not yet recruiting
- Atrial Fibrillation
- No OAC
- +4 more
- (no location specified)
Apr 28, 2023
Non-Valvular Atrial Fibrillation Treated or Untreated With Oral
Completed
- Non-Valvular Atrial Fibrillation (NVAF)
-
Tokyo, JapanLocal Institution
Mar 3, 2022
Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute
Recruiting
- Therapeutic Drug Monitoring
- Blood sampling to test drug level
-
Taipei, TaiwanNational Taiwan University Hospital
Mar 8, 2022
Aortic Valve Disease, Aortic Valve Stenosis, Stroke Trial in Nieuwegein (Continuation of oral anticoagulants, Interruption of
Recruiting
- Aortic Valve Disease
- +6 more
- Continuation of oral anticoagulants
- Interruption of oral anticoagulants
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Ziekenhuis
Feb 8, 2022
Subject Under Anticoagulant Trial in Marseille (an observational study)
Recruiting
- Subject Under Anticoagulant
- an observational study
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Aug 12, 2022
Intra-cardiac Thrombus, STEMI, Heart Failure Trial in France, Réunion (Vitamin K antagonist, Direct oral anticoagulant)
Not yet recruiting
- Intra-cardiac Thrombus
- +2 more
- Vitamin K antagonist
- Direct oral anticoagulant
-
Angers, France
- +33 more
Apr 11, 2023
Pulmonary Hypertension
Recruiting
- Pulmonary Arterial Hypertension
- Oral anticoagulant treatment
-
Clermont-Ferrand, France
- +3 more
Mar 16, 2022
Automated Indicators on Appropriateness of Oral Anticoagulant
Recruiting
- Healthcare Quality Indicators
- +6 more
-
Bordeaux, France
- +3 more
Feb 2, 2022
Atrial Fibrillation Trial (Patient education related oral anticoagulants (OACs))
Completed
- Atrial Fibrillation
- Patient education related oral anticoagulants (OACs)
- (no location specified)
Nov 22, 2021